Twitter | Pretraživanje | |
UCB News
A global biopharma company focusing on creating value for people living with neurology and immunology diseases. We are inspired by patients, driven by science.
1.992
Tweetovi
1.860
Pratim
9.998
Osobe koje vas prate
Tweetovi
UCB News 18 h
The second Monday of February is International where people come together to highlight problems faced by the 65 million people living with worldwide. Yet despite the high prevalence, many patients will not receive treatment
Reply Retweet Označi sa "sviđa mi se"
UCB News 4. velj
UCB scientists have discovered the first ‘small molecules’ that could inhibit TNF – a key protein involved in inflammatory diseases, including rheumatoid arthritis
Reply Retweet Označi sa "sviđa mi se"
UCB News 3. velj
Check out the new Data Transparency Policy section on our website
Reply Retweet Označi sa "sviđa mi se"
UCB News 29. sij
Everything we do at UCB starts with one simple question: How will this create value for people now and into the future? That’s our raison d’être
Reply Retweet Označi sa "sviđa mi se"
UCB News 28. sij
UCB is proud to announce an important treatment milestone in Japan. Learn more
Reply Retweet Označi sa "sviđa mi se"
UCB News proslijedio/la je tweet
pharma.be 23. sij
It is all about collective and individual responsibility to really change our behavior. Isabelle Béraud of ⁦ at the
Reply Retweet Označi sa "sviđa mi se"
UCB News 24. sij
The drug development process can take 10-15 years from early-stage discovery to marketing authorization. has the potential to accelerate this process and make it significantly more efficient. Find out more
Reply Retweet Označi sa "sviđa mi se"
UCB News 22. sij
that women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture? Read a summary of the findings published in the Journal of Bone and Mineral Research
Reply Retweet Označi sa "sviđa mi se"
UCB News proslijedio/la je tweet
Wirtschaft.NRW 13. sij
Beim Pharma-Unternehmen in Monheim am Rhein tauschte sich mit einem spannenden Panel über die Bedeutung der für regionale Standortentwicklung & internationale Wettbewerbsfähigkeit aus.
Reply Retweet Označi sa "sviđa mi se"
UCB News 10. sij
Based on a recent UCB survey, almost 1 in 5 patients living with reported having to reduce their working hours, and one in 8 said the condition meant they had to give up work completely.
Reply Retweet Označi sa "sviđa mi se"
UCB News 7. sij
Is a neglected condition? We asked patients
Reply Retweet Označi sa "sviđa mi se"
UCB News 30. pro
We’re counting down to 2020 - not just a new day or a new year but a new decade! Stay tuned for news on the 2020’s promising innovations
Reply Retweet Označi sa "sviđa mi se"
UCB News 23. pro
It’s a special time of the year all over the world. We want to show our appreciation to everyone who has helped us delivering new solutions to patients
Reply Retweet Označi sa "sviđa mi se"
UCB News 20. pro
UCB is playing its part in tackling the ‘silent epidemic’ of
Reply Retweet Označi sa "sviđa mi se"
UCB News 20. pro
There are approximately 5 million people living with rheumatoid arthritis in China, women are especially impacted. We are proud to support these patients by providing new treatment options. Learn more
Reply Retweet Označi sa "sviđa mi se"
UCB News 18. pro
We're supporting students interested in a career in . Find out what happened when 37 students visited our .
Reply Retweet Označi sa "sviđa mi se"
UCB News 16. pro
We're exploring how could help monitor treatment outcomes for patients with
Reply Retweet Označi sa "sviđa mi se"
UCB News 12. pro
Reply Retweet Označi sa "sviđa mi se"
UCB News 10. pro
Can help with early diagnosis of vertebral ? What do you think ?
Reply Retweet Označi sa "sviđa mi se"
UCB News 10. pro
is forecast to affect 12.9 million people by 2040. Read how could accelerate the development of new therapeutic options for people living with PD
Reply Retweet Označi sa "sviđa mi se"